The ANDA is held by its partner Natco Pharma Limited, India and Breckenridge plans to launch immediately. Everolimus TFOS is a kinase inhibitor indicated in adult and pediatric patients aged one year ...

Susumu Hijioka, MD, discussed how a lower dose of everolimus may help address certain adverse events like oral mucositis and hypoglycemia. Dose adjustments may benefit patients with unresectable or ...

Pneumonia symptoms can vary based on the cause and severity of the lung infection. For some, it might feel similar to the flu or be barely noticeable. For others, pneumonia can cause severe ...

Everolimus plus lanreotide resulted in a progression-free survival of 29.7 months in patients with gastroenteropancreatic neuroendocrine tumors, compared with 11.5 months with everolimus monotherapy.

The combination of everolimus plus lanreotide showed an improvement in progression-free survival and an acceptable safety profile vs everolimus monotherapy in gastroenteropancreatic neuroendocrine ...

Your doctor will usually call that pneumonia. If you don’t treat pneumonitis, it can start to scar your lungs. This is called pulmonary fibrosis, and it can be very serious. Your doctor will try ...

Background: Everolimus is an inhibitor of mammalian target of rapamycin complex 1. As mutations in TSC1 and TSC2, which cause partial-onset seizures associated with TSC, were found in focal cortical ...

Introduction: Pneumonitis is a relevant side effect after radiotherapy (RT) and immunotherapy with checkpoint inhibitors (ICIs). Since the effect is radiation dose dependent, the risk increases for ...